Pain final

0.0(0)
studied byStudied by 0 people
GameKnowt Play
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/148

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

149 Terms

1
New cards

Med for muscle issue

muscle relaxant

2
New cards

psychosocial meds

SNRI, tricyclic antidepressant

3
New cards

meds for neuropathic pain

gabapetenoid

4
New cards

gabapentinoid can’t be taken

prn

5
New cards

pregabalin has lower dosage than

gabapentin

6
New cards

nociplastic pain meds

SNRI, tricyclic antidepressant (also maybe gabapentinoids, acetaminophen, and NSAIDS?)

7
New cards

nociceptive pain meds

topical analgesic, NSAIDs, opioid, channel blockers

8
New cards

time to fall asleep

sleep latency

9
New cards

ideal sleep latency

0-30 min

10
New cards

desired sleep efficiency

>85%

11
New cards

graded exposure

progression of engagement along fear hierarchy, psychological

12
New cards

graded activity

progressive increase

13
New cards

isometrics are used early in rehab to produce analgesia with

certain tendon pains

14
New cards

aerobic exercise is appropriate for

all pain mechanisms

15
New cards

exercise impact on central inhibition

increases central inhibition (opioidergic and serotonergic)

16
New cards

exercise impact on central facilitation

reduces central facilitation (NMDA receptors not active)

17
New cards

exercise impacts

systemic inflammation and the immune system

18
New cards

sedentary lifestyle and chronic pain have a

bidirectional relationship

19
New cards

proposed mechanisms of neurodynamics

  • reduce immune response/inflammation from n. injury

  • reduce local perineurial and intramural edema

  • reduce hyperalgesia (mechanical and thermal(

  • reduce neural adhesions

20
New cards

neurodynamics could have

systemic effects

21
New cards

types of manual therapy

  • soft tissue based

  • nerve biased

  • joint based

    • mobs (low velocity)

    • manipulations (high velocity)

22
New cards

velocity of mobs

low

23
New cards

velocity of manipulations

high

24
New cards

STAR shoulder classification

screen flags, assign pathoanatomical diagnosis, assign rehab classification

25
New cards

LBP you should

screen for red flags, clarify symptom irritability, classify into treatment classification (manipulation, stabilization, special exercises, traction)

26
New cards

with low irritability, you can push

into resistance

27
New cards

with medium irritability, use

caution against high force mobs

28
New cards

with high irritability, push not

into tissue resistance

29
New cards

nerve treatment dosage

less is more, touch into symptoms, keep it low to avoid flareups

30
New cards

tendon/muscle exercise should not cause pain to be

≥4/10 before or after exercise

31
New cards

exercise for bone should have

no pain before/after

32
New cards

for nociplastic pain, address

neuroplasticity

33
New cards

top-down drivers

  • bad childhood experiences

  • depression

  • anxiety

  • stress

  • fear avoidance beliefs

34
New cards

bottom-up/peripheral drivers

  • tissue injury

  • muscle weakness

  • medical co-morbidities

35
New cards

Stages of GMI

L/R discrimination, explicit motor imagery, mirror therapy

36
New cards

SINSS model

Severity, irritability, nature, stage, stability

37
New cards

“why did things that were fine now cause pain?”

envelope of function (preventing boom/bust)

38
New cards

“will it ever go away?”

pain vs function

39
New cards

“why am I still in pain?”

alarm system

40
New cards

Cellular processes that can contribute to central sensitization

increase of membrane excitability, synaptic facilitation, disinhibition

41
New cards

nervous system changes resulting from central sensitization

development or increase in spontaneous activity, reduction in threshold for activation by peripheral stimuli, enlargement of receptive fields

42
New cards

enlargement of receptive fields refers to

conversion of nociceptive-specific neurons to wide dynamic neurons that now respond to both innocuous and noxious stimuli

43
New cards

sensitization can occur at

any point along the neural axis

44
New cards

maladaptive neuroplasticity

subcortical and cortical reorganization

45
New cards

central sensitization changes at

secondary nociceptive neuron

46
New cards

peripheral sensitization changes at

primary nociceptive neuron

47
New cards

peripheral sensitization cell body

in DRG

48
New cards

central sensitization cell body

in spinal cord

49
New cards

CSI is a… outcome measure

nociplastic

50
New cards

CSI>40 indicates

likely central sensitization

51
New cards

OA can cause

chronic pain, brain changes

52
New cards

ACL-R can cause

maladaptive neuroplasticity

53
New cards

chronic LBP can cause

tactile dysfunction, body image distortion

54
New cards

tendinopathy can cause

sensitization

55
New cards

MSK dx can cause

altered pain processing, impairments to CNS

56
New cards

central sensitization in neuropathic pain

neuroinflammation and glial cell activity, increased responsiveness of dorsal horn neurons (wind-up or temporal summation) likely cause and/or reduction in descending inhibition/cortical reorganization, unregulated NK1-R, decreased threshold for substance P to activate SC neuron, pro-inflammatory cytokines released from microglia

57
New cards

peripheral sensitization in neuropathic pain

up regulation of receptor channels at 1° afferent nociceptor (a delta), reduced threshold to responsiveness

58
New cards

c fiber cell bodies live in

DRG

59
New cards

NK1-R is a receptor for

substance P

60
New cards

possible causes of neuropathic pain

ectopic impulse generation at site of nerve injury or DRG (phantom limb pain), compression of nerve (vascular compromise), up regulation of TRPV1 and/or acid sensing channels @ 1° sensory afferent (peripheral sensitization)

61
New cards

neuropathic pain possible lesion sites/types

genetic disease affecting receptors and/or ion channels of peripheral nociceptive neuron, damage to peripheral nociceptive axon or myelin, SC lesion affecting spinothalamic tract, thalamic lesion

62
New cards

nerves need

blood, movement, and space

63
New cards

neuropathic pain is caused by

lesion or disease of somatosensory system

64
New cards

cerebellar lesions can/cannot cause neuropathic pain

CANNOT

65
New cards

somatosensory lesion can be in the

PNS or CNS

66
New cards

pain DETECT <12 indicates

unlikely neuropathic component to pain

67
New cards

pain DETECT ≥19 indicates

likely neuropathic component

68
New cards

S_LANSS <12 indicates

unlikely neuropathic component

69
New cards

S-LANSS ≥12 indicates

likely neuropathic component

70
New cards

spinothalamic tract, aka

anterolateral system

71
New cards

MCID on NPRS

2 points

72
New cards

NPRS

numeric pain rating scale

73
New cards

VAS MCID

20mm

74
New cards

nociceptive pain outcomes

VAS, NPRS

75
New cards

4 D’s of nociplastic pain

disproportionate pain, disproportionate aggravating/easing factors, diffuse pain/palpation tenderness, distress

76
New cards

3 S’s of neuropathic pain

subjective hx of nerve pathology, sensory deficits in dermatomal pattern, stretching nerve provokes

77
New cards

4 P’s of nociceptive pain

proportional, provokable, periodic, predictable

78
New cards

exercise therapy for neuropathic and nociplastic pain should take this approach

cognitive behavioral (including time-contingent approach)

79
New cards

exercise therapy for nociceptive pain should take this approach

pain contingent approach

80
New cards

pt ed for nociceptive

explain presumed source of nociception

81
New cards

pt ed for neuropathic

explain lesion or disease of nervous system and central sensitization

82
New cards

nociplastic pt ed

explain central sensitization

83
New cards

neuropathic is limited to

neuroanatomically plausible distributions

84
New cards

nociplastic outcome measures

CSI

85
New cards

neuropathic outcome measures

S-LANSS, painDETECT

86
New cards

nociceptive outcome measures

NPRS, VAS

87
New cards

CPM

ability of descending pain inhibitory mechanisms (central) to effectively inhibit pain following a painful stimulus (e.g. increased PPT after cold water bath)

88
New cards

wind-up

progressively increasing activity in dorsal horn cells following repetitive activation of primary afferent c fibers

89
New cards

temporal summation

increased pain response to repetitive noxious stimuli to C/A delta fibers at <3Hz, central sensitization results in steeper ramp up in responsiveness

90
New cards

neurogenic inflammation

nociceptors acting on adjacent tissues by releasing inflammatory mediators (can vasodilate and increase permeability)

91
New cards

process proposed to contribute to 2° hyperalgesia

heterosynaptic facilitation

92
New cards

heterosynaptic faciliation

interneuronal facilitation of adjacent spinal projection pathways, may explain expansion of pain beyond area of insult (nosy neighbors)

93
New cards

process proposed to contribute to primary hyperalgesia

homosynpatic facilitation

94
New cards

homosynaptic facilitation

repeated peripheral input sensitizes dorsal horn projection neurons in nociceptive pathway

95
New cards

central sensitization

increased responsiveness of dorsal horn (spinal cord) neurons (wind up or temporal summation) and/or reduction in descending inhibition

96
New cards

central sensitization has increase in activity of

microglia and astrocytes at dorsal horn

97
New cards

peripheral sensitization

reduced threshold of peripheral nociceptive neurons (A delta, C fibers) and/or increased responsiveness

98
New cards

TRP

transient receptor potential

99
New cards

in peripheral sensitization, channels

TRP and sodium/calcium channels may have increased expression and/or responsiveness, this makes it easier to activate neurons (which increase peripheral nociceptive input to nervous system)

100
New cards

C fibers

slow, small diameter, unmyelinated, nociception, cell body in DRG, associated with dull, subacute, longer lasting pain, poorly localizezd